Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | -0.2x - -0.3x | -0.2x |
| Historical Pb Multiple | 0.6x - 5.0x | 1.3x |
| Fair Value | C$0.087 - C$0.096 | C$0.092 |
| Upside | -48.7% - -43.3% | -46.0% |
| Benchmarks | - | Full Ticker |
| Cresco Labs Inc. | - | OTCPK:CRLB.F |
| Curaleaf Holdings, Inc. | - | OTCPK:CURL.F |
| 4Front Ventures Corp. | - | OTCPK:FFNT.F |
| Ayr Wellness Inc. | - | OTCPK:AYRW.F |
| Verano Holdings Corp. | - | OTCPK:VRNO.F |
| The Cannabist Company Holdings Inc. | - | NEOE:CBST |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| CRLB.F | CURL.F | FFNT.F | AYRW.F | VRNO.F | CBST | |||
| OTCPK:CRLB.F | OTCPK:CURL.F | OTCPK:FFNT.F | OTCPK:AYRW.F | OTCPK:VRNO.F | NEOE:CBST | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| Latest Twelve Months | 73.5% | -20.7% | 31.3% | -317.4% | -184.4% | -4.8% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -22.9% | -19.1% | -170.4% | -39.4% | -12.8% | -46.7% | ||
| Prior Fiscal Year | -23.2% | -17.1% | -19.8% | -18.6% | -12.5% | -34.4% | ||
| Latest Fiscal Year | -10.4% | -17.3% | -45.9% | -77.5% | -38.9% | -23.1% | ||
| Latest Twelve Months | -6.7% | -20.7% | -46.6% | -77.5% | -40.8% | -43.3% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | -28.7% | -16.6% | -237.0% | -20.2% | -7.8% | -175.1% | ||
| Prior Fiscal Year | -31.0% | -19.7% | -64.9% | -12.2% | -9.1% | -125.4% | ||
| Latest Twelve Months | -10.0% | -28.6% | NM | -74.8% | -32.2% | -1405.5% | ||
| Next Fiscal Year | -15.1% | -13.0% | 82.7% | -47.7% | 43.5% | 255.5% | ||
| Two Fiscal Years Forward | -11.1% | -14.4% | -190.2% | -72.5% | 32.6% | 77.7% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 0.6x | 1.6x | 0.0x | 0.0x | 0.5x | 0.2x | ||
| Price / LTM EPS | -7.5x | -7.6x | -0.1x | 0.0x | -1.3x | -0.4x | ||
| Price / Book | 1.0x | 2.3x | -0.1x | 0.0x | 0.5x | -0.4x | ||
| Price / Fwd Book | 0.9x | 2.7x | 0.0x | 0.0x | 0.3x | 0.3x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | -0.1x | 0.5x | 2.3x | |||||
| Historical P/B Ratio | 0.6x | 1.3x | 5.0x | |||||
| Selected P/B Multiple | -0.2x | -0.2x | -0.3x | |||||
| (x) Book Value | (138) | (138) | (138) | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | CRLB.F | CURL.F | FFNT.F | AYRW.F | VRNO.F | CBST | |
| Value of Common Equity | 350 | 2,032 | 1 | 5 | 438 | 61 | |
| (/) Shares Outstanding | 356.2 | 764.6 | 916.4 | 116.8 | 361.8 | 499.1 | |
| Implied Stock Price | 0.98 | 2.66 | 0.00 | 0.04 | 1.21 | 0.12 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.72 | |
| Implied Stock Price (Trading Cur) | 0.98 | 2.66 | 0.00 | 0.04 | 1.21 | 0.17 | |
| Trading Currency | USD | USD | USD | USD | USD | CAD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.72 | |